ASH 2022 Conference Coverage

 

ASH 2022 Conference Coverage
M

ASH 2022 Long-Term Outcomes of Patients With TDT Followed Up to 8 Years Post-Treatment With Betibeglogene Autotemcel Gene Therapy and Predictors of Successful Treatment Outcomes in Phase 3 Trials

By ASH 2022 Conference Coverage FEATURING Mark Walters
By ASH 2022 Conference Coverage FEATURING Mark Walters
89 views
January 5, 2023
0 Comments
Login to view comments. Click here to Login

Featured Video

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay
Benign Hematology
05:00
ASH 2022 Conference Coverage

Cognitive Impairment in Patients With ITP

Feat. C. Vladescu
37:56
ASH 2022 Conference Coverage

Updates on Thrombosis & COVID-19

Feat. B. Hunt
16:56
ASH 2022 Conference Coverage

ASH 2022: What's Hot in Sickle Cell Disease Research 2022

Feat. E. Klings
08:41
ASH 2022 Conference Coverage

ASH 2022 Long-Term Outcomes of Patients With TDT Followed Up to 8 Ye…

Feat. M. Walters
06:01
ASH 2022 Conference Coverage

ASH 2022: Mitapivat Improves Iron Overload in Patients With Pyruvate…

Feat. K. Kuo
05:42
ASH 2022 Conference Coverage

ASH 2022 Health-Related QOL in Patients With Hemophilia A or B With …

Feat. A. Shapiro
11:26
ASH 2022 Conference Coverage

ASH 2022 Phase 3, Multicenter, Double-Blinded, Placebo-Controlled, R…

Feat. C. Broome
11:03
ASH 2022 Conference Coverage

ASH 2022 Low-Molecular-Weight Heparin vs. Standard Pregnancy Care fo…

Feat. S. Middeldorp
21:11
ASH 2022 Conference Coverage

ASH 2022: Immune Response to SARS-CoV-2 and Vaccination

Feat. S. Crotty
07:35
ASH 2022 Conference Coverage

ASH 2022 Hydroxyurea Dosing in Very Young Children With Sickle Cell …

Feat. W. Wang
10:53
ASH 2022 Conference Coverage

ASH 2022 New Biological Insights on Clonal Evolution in Aplastic Ane…

Feat. A. Kulasekararaj
09:20
ASH 2022 Conference Coverage

ASH 2022 Phase III APPLY-PNH Study: Oral Monotherapy With Iptacopan …

Feat. R. de Latour
24:02
ASH 2022 Conference Coverage

ASH 2022 Controversies in the Prevention of VTE for Medical Inpatien…

Feat. A. Spyropoulos
04:37
ASH 2022 Conference Coverage

ASH 2022 Outcomes of Older Patients With Aplastic Anemia Treated Wit…

Feat. J. Senapati
12:56
ASH 2022 Conference Coverage

ASH 2022 Lentiviral-Mediated Gene Therapy for Adults and Children Wi…

Feat. A. Shah